A detailed history of J. Safra Sarasin Holding Ag transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 822,734 shares of GILD stock, worth $79.8 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
822,734
Previous 838,143 1.84%
Holding current value
$79.8 Million
Previous $57.5 Billion 19.99%
% of portfolio
1.2%
Previous 1.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$66.59 - $83.99 $1.03 Million - $1.29 Million
-15,409 Reduced 1.84%
822,734 $69 Billion
Q2 2024

Jul 30, 2024

BUY
$63.15 - $72.88 $52.9 Million - $61.1 Million
838,143 New
838,143 $57.5 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $122B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.